Cancer remains one of the leading causes of death worldwide, and despite advancements in diagnosis and treatment, it continues to impose a significant health burden globally. Researchers have now started exploring various ...
The Korea Research Institute of Standards and Science has successfully developed a nanomaterial capable of simultaneously performing cancer diagnosis, treatment, and immune response induction. Compared to conventional nanomaterials ...
The drug pipeline—the process through which a potential new drug gets discovered, tested, approved, and marketed—is a notoriously long and arduous process, and even the most promising drugs can languish or die on the ...
Researchers have developed an innovative nano-immune agonist that significantly improves immunotherapy outcomes for melanoma—a highly aggressive and hard-to-treat form of skin cancer.
Traditionally, radiation, chemotherapy, and surgery have been the most common ways to remove and destroy malignant cells. However, because these treatments can also damage healthy cells, they often have significant side effects. ...
Photoimmunotherapy is an innovative cancer treatment that combines phototherapy with immunotherapy to selectively target and destroy cancer cells. In photoimmunotherapy, a photosensitizer or nanomaterial is introduced into ...
Melanoma is a fast-progressing skin cancer characterized by a high mortality rate after metastasis. Local chemotherapy could be considered a therapeutic approach only in stage 0 of progression (in situ melanoma) and in the ...
Atherosclerosis is the build-up of plaque in the arteries which causes their narrowing. It is a primary cause of ischemic heart disease (IHD) and ischemic stroke (IS), both of which are major contributors to the 17.9 million ...
A research group from Ningbo Institute of Materials Technology and Engineering (NIMTE) of the Chinese Academy of Sciences (CAS) developed a novel method for idiopathic pulmonary fibrosis (IPF) therapy by transplanting mesenchymal ...
Researchers at the University of Bayreuth have established a new optogenetic approach that can control the bacterial production of proteins at the mRNA level using blue light. The new system gates the activation of the genetic ...
